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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S165Results: We identiﬁed 281,356 patients with an incident clinical diag-
nosis of OA. Among these, 91,515(32.5%) and 211,844(75.3%) purchased
SYSADOA and paracetamol respectively. Paracetamol users were older
(mean 68.4 VS 63.6 years; p<0.001), and more likely to have comorbid
conditions such as hypertension (56.8% vs 46.9%), type 2 diabetes (19.2%
vs 13.5%), and ischaemic heart disease (4.1% vs 2.1%). Knee OAwas more
common among users of SYSADOA (52.2%) than in paracetamol users
(42.0%).
Incidence of use of Glucosamin and Diacerein decreased from 12.0/100
person-years (99%CI 11.6-12.5) and 4.2/100(4.0-4.5) in 2006 to 5.0/
100(4.6-5.4) and 1.4/100(1.2-1.6) in 2011 respectively. By contrast,
incidence of CS use increased from 9.3/100(8.9-9.7) to 14.1/100(13.4-
14.7) in this same period [Figure].
Conclusions: Almost 1/3 of the newly diagnosed OA patients start
treatment with SYSADOA in Spain. When compared to users of para-
cetamol, new users of SYSADOA are younger, more likely to suffer knee
OA, and have a better cardiovascular risk proﬁle.
Incidence of use of the 3 available oral SYSADOA has changed in the last
few years: while new users of CS increased yearly, numbers of incident
glucosamin and diacerein users have decreased.Ă313
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Purpose: Mortality is high amongst patients undergoing total hip
arthroplasty (THA). The causes for this may include patient, surgical,
and implant-related variables, but data on these are scarce.
We conducted a retrospective cohort study including information on
patient characteristics from primary care records, and surgical and
implant-related variables from the local joint registry to examine the
association between cement use and mortality following THA surgery.
Methods: Study design and population: We used data from the Catalan
Joint Registry (RACAT), and linked it (85% linked) to computerized
primary care records (SIDIAP Database). We identiﬁed patients aged
>¼40 years undergoing primary THA or resurfacing registered in the
resulting dataset in the period 1/1/2005-31/07/2012.
We excluded patients with a history of hip fracture as indication for
surgery (n¼5,268) and, amongst the remaining, those receiving uni-
monoblock/uni-modular (n¼481), or other (bipolar/tripolar and short-
stem, n¼553) hip implants.
- Outcome: Time from primary THA surgery to death was
primary outcome.
- Main exposure: Use of cement for THA ﬁxation was the main
independent variable, and this was categorized into Cemented
vs Hybrid/Reverse hybrid vs Cementless.
Ă- Potential confounders: we deﬁned a priori a set of potential
confounders, including: type of prosthesis (metal-on-metal
THA, metal-on-polymer THA, ceramics-on-ceramics THA,
ceramics-on-polymer THA, resurfacing), indication for surgery
(osteoarthritis vs rheumatoid arthritis vs other inﬂammatory
arthritides vs others), age, sex, socio-economic status, Charlson
co-morbidity index, alcohol drinking, smoking status, body
mass index, and type 2 diabetes mellitus.
- Analysis: uni and multivariable Cox regression models were
ﬁtted to estimate Hazard Ratio (HR) and 95% Conﬁdence
Interval of mortality post-THA according to cement use
(cemented, hybrid, cementless), as deﬁned above, adjusting for
confounding variables.
Results: 7,690 patients undergoing THA were included, and observed
for a median (inter-quartile range) of 2.7 (1.4-4.4) years. 126/5,104
(2.5%) participants receiving cementless THA died, compared to 67/
1,820 (3.7%) and 60/766 (7.8%) amongst those who had hybrid and
cemented THA respectively (Chi2 p-val<0.001) [Figure].
This was equivalent to age and gender-adjusted HRs of 1.07 [0.79-1.46]
for hybrid and HR 1.76 [1.25-2.47] for cemented procedures. The
observed effect of cemented THA on mortality post-surgery remained
signiﬁcant after multivariable adjustment: HR 1.63 [1.15-2.31].
Conclusions: We have demonstrated that patients undergoing
cemented THA are at 60% higher risk of death in the years following
surgery than those receiving cementless arthroplasty. This effect is
independent of patient clinical characteristics, socio-economic status,
indication for surgery, and prosthesis type. More data on the systemic
effects of cement are urgently needed.314
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Purpose: There is evidence that metabolic factors play an important
role in the natural history of osteoarthritis. Metabolic syndrome is
associated with alterations in inﬂammation, superoxide anion
production, advanced gylcation end products, adipokines, impaired
ﬁbrinolysis which have been shown to effect cartilage, bone, and liga-
ment biology. Recent studies have found a cross sectional relationship
metabolic syndrome and KL grade of knee OA.
